AlloVir Inc (ALVR)
0.7766
+0.03
(+3.35%)
USD |
NASDAQ |
May 17, 16:00
0.7766
0.00 (0.00%)
After-Hours: 20:00
AlloVir Price to Book Value: 0.7404 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 0.7404 |
| May 16, 2024 | 0.7175 |
| May 15, 2024 | 0.7161 |
| May 14, 2024 | 0.7372 |
| May 13, 2024 | 0.7162 |
| May 10, 2024 | 0.75 |
| May 09, 2024 | 0.7795 |
| May 08, 2024 | 0.7465 |
| May 07, 2024 | 0.7604 |
| May 06, 2024 | 0.77 |
| May 03, 2024 | 0.7614 |
| May 02, 2024 | 0.7695 |
| May 01, 2024 | 0.7728 |
| April 30, 2024 | 0.7579 |
| April 29, 2024 | 0.7771 |
| April 26, 2024 | 0.7605 |
| April 25, 2024 | 0.7633 |
| April 24, 2024 | 0.7442 |
| April 23, 2024 | 0.7546 |
| April 22, 2024 | 0.728 |
| April 19, 2024 | 0.7158 |
| April 18, 2024 | 0.708 |
| April 17, 2024 | 0.7222 |
| April 16, 2024 | 0.7012 |
| April 15, 2024 | 0.7119 |
| Date | Value |
|---|---|
| April 12, 2024 | 0.7315 |
| April 11, 2024 | 0.7368 |
| April 10, 2024 | 0.7162 |
| April 09, 2024 | 0.7096 |
| April 08, 2024 | 0.7028 |
| April 05, 2024 | 0.7124 |
| April 04, 2024 | 0.7247 |
| April 03, 2024 | 0.7322 |
| April 02, 2024 | 0.7321 |
| April 01, 2024 | 0.7677 |
| March 28, 2024 | 0.5948 |
| March 27, 2024 | 0.60 |
| March 26, 2024 | 0.591 |
| March 25, 2024 | 0.5992 |
| March 22, 2024 | 0.5929 |
| March 21, 2024 | 0.6074 |
| March 20, 2024 | 0.5873 |
| March 19, 2024 | 0.5878 |
| March 18, 2024 | 0.5767 |
| March 15, 2024 | 0.6137 |
| March 14, 2024 | 0.5726 |
| March 13, 2024 | 0.5739 |
| March 12, 2024 | 0.5831 |
| March 11, 2024 | 0.5709 |
| March 08, 2024 | 0.5736 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.397
Minimum
Dec 29 2023
7.981
Maximum
Jan 11 2021
3.009
Average
2.528
Median
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.808 |
| AIM ImmunoTech Inc | 2.107 |
| IGC Pharma Inc | 3.942 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 2.806 |
Price to Book Value Related Metrics
| Price | 0.7766 |
| Earnings Yield | -214.1% |
| Market Cap | 89.17M |